Home>Publications>Use of propensity scores to assess comparability of treatment groups in a registry program
Rothman K, Huisman M, Lip G, Diener H, Dubner S, Ma C, Zint C, Teutsch C, Shoof N, Paquette M, Kleine E, Bartels D, Halperin J, the GLORIA AT study team . Use of propensity scores to assess comparability of treatment groups in a registry program. Presented at the 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; October 25, 2014. Taipei, Taiwan.
Abstract not available at this time
RTI Health Solutions®
The power of knowledge. The value of understanding.
Steeped in a tradition of rigor and process, we maintain a legacy of setting the scientific standards within our industry. We employ the right approaches and proven research practices to analyze evidence and draw meaningful insights. Our uncompromisingly ethical and objective researchers ensure that results will hold up to scrutiny and reveal the benefits, risks, value and potential of your products. Learn more.